Targeted exosome-based nanoplatform for new-generation therapeutic strategies
Authors:
Open Access
- 25 March 2024
- journal article
- review article
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (3) , 032002
Abstract
Exosomes, typically 30–150 nm in size, are lipid-bilayered small-membrane vesicles originating in endosomes. Exosome biogenesis is regulated by the coordination of various mechanisms whereby different cargoes (e.g. proteins, nucleic acids, and lipids) are sorted into exosomes. These components endow exosomes with bioregulatory functions related to signal transmission and intercellular communication. Exosomes exhibit substantial potential as drug-delivery nanoplatforms owing to their excellent biocompatibility and low immunogenicity. Proteins, miRNA, siRNA, mRNA, and drugs have been successfully loaded into exosomes, and these exosome-based delivery systems show satisfactory therapeutic effects in different disease models. To enable targeted drug delivery, genetic engineering and chemical modification of the lipid bilayer of exosomes are performed. Stimuli-responsive delivery nanoplatforms designed with appropriate modifications based on various stimuli allow precise control of on-demand drug delivery and can be utilized in clinical treatment. In this review, we summarize the general properties, isolation methods, characterization, biological functions, and the potential role of exosomes in therapeutic delivery systems. Moreover, the effective combination of the intrinsic advantages of exosomes and advanced bioengineering, materials science, and clinical translational technologies are required to accelerate the development of exosome-based delivery nanoplatforms.Keywords
Funding Information
- Science and Technology Department of Jilin Province (20220303002SF)
- Norman Bethune Program of Jilin University (2022B02)
- The National Natural Science Foundation of China (81971105)
- Norman Bethune Health Science Center of Jilin University (2022JBGS03)
- Jilin Provincial Key Laboratory (YDZJ202302CXJD017)
This publication has 202 references indexed in Scilit:
- Engineering and Characterization of an Artificial Drug‐Carrying Vesicles Nanoplatform for Enhanced Specifically Targeted Therapy of GlioblastomaAdvanced Materials, 2023
- CD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated PyroptosisAdvanced Healthcare Materials, 2023
- Specific anti‐glioma targeted‐delivery strategy of engineered small extracellular vesicles dual‐functionalised by Angiopep‐2 and TAT peptidesJournal of Extracellular Vesicles, 2022
- A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic NanovaccinesAdvanced Science, 2021
- Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and ValidationBiotechnology Journal, 2019
- Chemical Modulation of Bioengineered Exosomes for Tissue‐Specific BiodistributionAdvanced Therapeutics, 2019
- Exosome DNA: Critical regulator of tumor immunity and a diagnostic biomarkerJournal of Cellular Physiology, 2019
- A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJAMA Oncology, 2016
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006
- Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cellsInternational Journal of Cancer, 1998